"From your first meeting with your care-management team to ongoing support from our survivorship program long after your treatment is complete, the health care professionals at the Graham Cancer Center are at your service."

During the past decade, Christiana Care/Helen F. Graham Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christiana Care/Helen F. Graham Cancer Center" #1 sponsor was "Incyte Corporation" with 2 trials, followed by "BioMed Valley Discoveries, Inc" with 1 trials sponsored, "Christiana Care Health Services" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Tizona Therapeutics, Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christiana Care/Helen F. Graham Cancer Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Christiana Care/Helen F. Graham Cancer Center" are "Advanced Solid Tumor" (1 trials), "BRAF Gene Alteration" (1 trials), "BRAF Gene Mutation" (1 trials), "Cancer" (1 trials) and "Locally Advanced Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Christiana Care/Helen F. Graham Cancer Center" in a lesser frequency.

Most popular intervention types in "Christiana Care/Helen F. Graham Cancer Center" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm A Directed exercise program" (1 trials), "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "Observation" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christiana Care/Helen F. Graham Cancer Center" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Christiana Care/Helen F. Graham Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Christiana Care/Helen F. Graham Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Christiana Care/Helen F. Graham Cancer Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".